Results 21 to 30 of about 14,685 (216)

Visual BOLD Response in Late Blind Subjects with Argus II Retinal Prosthesis.

PLoS Biology, 2016
Retinal prosthesis technologies require that the visual system downstream of the retinal circuitry be capable of transmitting and elaborating visual signals.
E Castaldi, G M Cicchini, L Cinelli, L Biagi, S Rizzo, M C Morrone   +5 more
doaj   +1 more source

First Retinal Implant Surgery

Vision Pan-America, 2013
First Retinal Implant ...
Fernando Arevalo
doaj   +1 more source

Rhegmatogenous Retinal Detachment with a High Risk of Proliferative Vitreoretinopathy Treated with Episcleral Surgery and an Intravitreal Dexamethasone 0.7-mg Implant

Case Reports in Ophthalmology, 2013
Purpose: To report a case of rhegmatogenous retinal detachment with a high risk of proliferative vitreoretinopathy (PVR) effectively treated with episcleral surgery and an intravitreal dexamethasone 0.7-mg implant.
Michele Reibaldi, Andrea Russo, Antonio Longo, Vincenza Bonfiglio, Maurizio G. Uva, Caterina Gagliano, Mario D. Toro, Teresio Avitabile   +7 more
doaj   +1 more source

Designing artificial senses: steps from physiology to clinical implementation

Swiss Medical Weekly, 2019
Our senses are the main information channels through which we perceive and interact with the world. Consequently, the physical and social functioning of patients suffering from severe sensory disabilities is limited on several levels.
Angélica Pérez Fornos, Raymond Van de Berg, Jörg Sommerhalder, Nils Guinand   +3 more
doaj   +1 more source

Progress on Designing a Chemical Retinal Prosthesis

Frontiers in Cellular Neuroscience, 2022
The last major review of progress toward a chemical retinal prosthesis was a decade ago. Many important advancements have been made since then with the aim of producing an implantable device for animal testing.
Jiajia Wu, Corey M. Rountree, Sai-Siva Kare, Pradeep Kumar Ramkumar, John D. Finan, John B. Troy   +5 more
doaj   +1 more source

An Argus II Case Report

Beyoglu Eye Journal, 2017
The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, USA) is the first US Food and Drug Administration-approved retinal implant.
İrfan Perente, Gürkan Erdoğan, Muhittin Taşkapılı   +2 more
doaj   +1 more source

To study the effect of intravitreal ozurdex implant in cases of retinal vein occlusion

Kerala Journal of Ophthalmology, 2022
Introduction: Retinal vein obstruction is one of the leading causes of severe vision impairment and blindness with treatment options mainly including laser, vascular endothelial growth factors, and steroids.
Shailender K Chaudhary, Saloni Gupta, Gangadhar Thellam, Rupali Tyagi, Sahil Agrawal   +4 more
doaj   +1 more source

Dexamethasone Implant Migration through an Iris Coloboma

Case Reports in Ophthalmology, 2020
Ozurdex® 0.7 mg (dexamethasone 0.7 mg implant, Allergan, Dublin, Ireland), an intravitreal biodegradable implant, is indicated for cystoid macular edema due to various causes.
Yoav Glidai, Shulamit Schwartz, Eyal Cohen   +2 more
doaj   +1 more source

Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report

BMC Ophthalmology, 2020
Background Dexamethasone intravitreal implants (0.7 mg) (Ozurdex®, Allergan Inc., Madison, NJ) are FDA approved for managing macular oedema (ME) of retinal vein occlusion (RVO).
Zhi-Yong Zhang, Xiu-Yun Liu, Tao Jiang
doaj   +1 more source

Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion

Molecules, 2022
Central retinal vein occlusion (CRVO) is a visually disabling condition resulting from a thrombus in the major outflow vessel of the eye. The inflammatory response in CRVO is effectively treated with a dexamethasone (DEX) intravitreal implant. Uncovering
Lasse Jørgensen Cehofski, Anders Kruse, Mads Odgaard Mæng, Benn Falch Sejergaard, Anders Schlosser, Grith Lykke Sorensen, Jakob Grauslund, Bent Honoré, Henrik Vorum   +8 more
doaj   +1 more source